Alzamend Neuro, Inc. (ALZN)
2.37
+0.04
(+1.72%)
USD |
NASDAQ |
Jan 13, 16:00
2.36
-0.01
(-0.42%)
After-Hours: 20:00
Alzamend Neuro EPS Diluted (Quarterly): -0.296 for Oct. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Medpace Holdings, Inc. | 3.857 |
| Embecta Corp. | 0.4485 |
| BrightSpring Health Services, Inc. | 0.2562 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.001M |
| Total Expenses (Quarterly) | 1.001M |
| Enterprise Value | 2.992M |
| Earnings Yield | -231.9% |
| Normalized Earnings Yield | -231.89 |